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Liver Transplantation 
URING THE LAST FEW YEARS there has tively low immediate mortality of 10% or 
single organ system. There are sound rea- The most effective agent for mitigation 
sons for this enthusiasm. Many patients of rejection has been a~athioprine.~ Un- 
have had considerable prolongation of fortunately, this drug is a hepatotoxic 
life by virtue of chronically functioning agent which, even in small doses, causes 
homografts; in our experience more acute liver injury in the majority of ani- 
than 50% of the patients treated from I? mals w~thin a few days after beginning 
to 3 years ago are still alive, having had administration (4). This high degree of 
continuous urine excretion by their new toxicity is apparently specific for the dog; 
kidneys during these intervals. nevertheless, several cases of "hepatitis" 
In view of these encouraging results and have been observed in azathioprine-treated 
those from several other centers (I), it humans long after renal homotransplanta- 
has been natural to think of extending tion. The therapeutic dilemma is evident. 
comparable replacement therapy to dis- At present, it is necessary to use a liver 
eases that result in functional failure of poison to prevent the effects of liver re- 
other organs. At present, liver transplanta- jection. 
tion appears to offer the most immediate In spite of this handicap, long-term sur- 
possibility of clinical utility. Because of vival has been obtained after orthotopic 
the therapeutic implications involved for liver transplantation in the experimental 
patients dying with hepatic failure or he- animal. In a recently reported series of 
patic carcinoma, a sober look at the prob- nearly 100 canine liver homotransplants 
lem of homotransplantation of the liver (4), the potentiation of homograft function 
is in order. The principal hope that homo- obtained was comparable to that reported 
transplantation of the liver may some day after homotransplantation of the dog kid- 
be a practical undertaking derives from ney. The four longest survivals from this 
studies with the dog. study are now over 1 year, with a maxi- 
The most incisive canine experiments mum of 20 ~ ~ ~ o n t h s .  
; have involved orthotopic transplantation The great variability in response of the 
: in which the recipient liver is removed and animals to the homograft is a matter of 
replaced with a normally revascularized interest. About one fifth of the dogs being 
homograft (2, 3). Postoperatively, there can treated with azathioprine alone had clini- 
be no argulnent about the presence or ab- cal evidence of rejection, and their trans- 
of transplant viability since survival plants in general had little histologic 
2 PrOvldes proof of continuous function. I ~ ~ . ~ . ~ ,  B ~ m ~ g h l  Wellcome & co., Tucka. 
' n i s  procedure can be done with the rela- hoe, N. Y. 
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change when biopsied many months after should not imply that clinical applica 
operation. At the other end of the spec- will be comparably easy. The implica 
trum, approximately one third underwent that patients can be benefited by such 
overwhelmingly immunologic repudiation operations is still only a hope. T o  date, 
provement in homograft function occurred are almost certain to be consisten.tly en. 
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respective of its source. More recent stud- 
In spite of these difficulties pathologic ies (13) have demonstrated that nonhepatic 
Such considerations become of the ut- 
the homograft atrophy is at least partially 
the pelvis, one of the paravertebral gutters, preparation (14). 
In addition to these physiologic consid- 
EDITORIAL 
0the.r the spleen and left kidney had to homograft function that is usually present . 
be excised for the same reason. 
histologic injury seemed more advanced acceptable. 
than in the orthotopic cases. Instead, the critical improvements will 
In  view of the uniform failure to date, be to minimize rejection or to avoid it 
the question of further clinical trials with altogether. This may be done in one of 
either orthotopic or auxiliary transplanta- two ways, singly or in combination. First, 
tion must now be re-examined. That  such perfection of human histocompatibility 
efforts will be made seems inevitable. In- analysis may, allow selection of cadaveric 
hospital. But what are the necessary cir- niques of immunosuppression will be re- 
cumstances? It  seems clear that major quired. These must have greater specificity 
changes in management will be necessary. so that protection of the graft is more com- 
Presently, the most important deficien- plete, without the diffuse crippling of host 
cies are in the immunosuppressive regimen. immunologic potential which characterizes 
T h e  combination of agents which has been the present methods. T h e  task is a large 
used with some success after clinical renal but necessary one which depends upon 
transplantation also apparently provides research in the animal laboratory and 
comparable protection from immunologic within the simpler experimental protocol 
injury to the liver homograft, but their use of clinical renal homotransplantation. 
involves a greater risk both to the trans- IVithout such improvements, further ef- 
plant and to the recipient. Both steroids forts at clinical hepatic homotransplanta- 
and azathioprine may cause nonimmuno- tion will not connote progress, but only 
logically mediated liver damage. The  prob- fruitless repetition. 
lems of pulmonary and generalized sepsis THOMAS E. STARZL, M.D., PH.D. 
that have plagued efforts at renal trans- THOMAS L. MARCHIORO, M.D. 
plantation have been almost uniformly TANOUS D. FARIS, N.D. 
observed after the more complicated and 
traumatic hepatic operations. The  dose REFERENCES 
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